BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 20031625)

  • 1. Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves.
    Bossé Y; Miqdad A; Fournier D; Pépin A; Pibarot P; Mathieu P
    Circ Cardiovasc Genet; 2009 Oct; 2(5):489-98. PubMed ID: 20031625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
    Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
    Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerotic inflammation triggers osteogenic bone transformation in calcified and stenotic human aortic valves: still a matter of debate.
    Anger T; Carson W; Weyand M; Daniel WG; Hoeher M; Garlichs CD
    Exp Mol Pathol; 2009 Feb; 86(1):10-7. PubMed ID: 19084515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased thrombospondin-2 in human fibrosclerotic and stenotic aortic valves.
    Pohjolainen V; Mustonen E; Taskinen P; Näpänkangas J; Leskinen H; Ohukainen P; Peltonen T; Aro J; Juvonen T; Satta J; Ruskoaho H; Rysä J
    Atherosclerosis; 2012 Jan; 220(1):66-71. PubMed ID: 22035575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
    Kaden JJ; Bickelhaupt S; Grobholz R; Vahl CF; Hagl S; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
    J Heart Valve Dis; 2004 Jul; 13(4):560-6. PubMed ID: 15311861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins.
    Anger T; Pohle FK; Kandler L; Barthel T; Ensminger SM; Fischlein T; Weyand M; Stumpf C; Daniel WG; Garlichs CD
    Exp Mol Pathol; 2007 Dec; 83(3):435-42. PubMed ID: 17490641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation.
    Pohjolainen V; Taskinen P; Soini Y; Rysä J; Ilves M; Juvonen T; Ruskoaho H; Leskinen H; Satta J
    Hum Pathol; 2008 Nov; 39(11):1695-701. PubMed ID: 18701137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2.
    Yang X; Fullerton DA; Su X; Ao L; Cleveland JC; Meng X
    J Am Coll Cardiol; 2009 Feb; 53(6):491-500. PubMed ID: 19195606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
    Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
    Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
    Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
    Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene polymorphisms leading to calcified and stenotic aortic valves].
    Anger T; Ekici AB; Daniel WG; Garlichs CD
    Herz; 2006 Oct; 31(7):635-43. PubMed ID: 17072776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
    Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
    Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor Egr-1 in calcific aortic valve disease.
    Ghazvini-Boroujerdi M; Clark J; Narula N; Palmatory E; Connolly JM; DeFelice S; Xu J; Jian B; Hazelwood S; Levy RJ
    J Heart Valve Dis; 2004 Nov; 13(6):894-903. PubMed ID: 15597579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin treatment and gene expression of anti-atherogenic factor C-type natriuretic peptide system in stenotic aortic valves.
    Peltonen T; Ohtonen P; Näpänkangas J; Ohukainen P; Ruskoaho H; Taskinen P
    J Heart Valve Dis; 2011 Sep; 20(5):545-51. PubMed ID: 22066359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis.
    Peltonen TO; Taskinen P; Soini Y; Rysä J; Ronkainen J; Ohtonen P; Satta J; Juvonen T; Ruskoaho H; Leskinen H
    Circulation; 2007 Sep; 116(11):1283-9. PubMed ID: 17709640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins stimulate RGS-regulated ERK 1/2 activation in human calcified and stenotic aortic valves.
    Anger T; El-Chafchak J; Habib A; Stumpf C; Weyand M; Daniel WG; Hombach V; Hoeher M; Garlichs CD
    Exp Mol Pathol; 2008 Oct; 85(2):101-11. PubMed ID: 18671964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.
    Kaden JJ; Dempfle CE; Grobholz R; Fischer CS; Vocke DC; Kiliç R; Sarikoç A; Piñol R; Hagl S; Lang S; Brueckmann M; Borggrefe M
    Cardiovasc Pathol; 2005; 14(2):80-7. PubMed ID: 15780799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2.
    Yang X; Meng X; Su X; Mauchley DC; Ao L; Cleveland JC; Fullerton DA
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):1008-15. PubMed ID: 19664780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower serum calcium levels are associated with greater calcium hydroxyapatite deposition in native aortic valves of male patients with severe calcific aortic stenosis.
    Ortlepp JR; Pillich M; Schmitz F; Mevissen V; Koos R; Weiss S; Stork L; Dronskowski R; Langebartels G; Autschbach R; Brandenburg V; Woodruff S; Kaden JJ; Hoffmann R
    J Heart Valve Dis; 2006 Jul; 15(4):502-8. PubMed ID: 16901043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis.
    Mazzone A; Epistolato MC; De Caterina R; Storti S; Vittorini S; Sbrana S; Gianetti J; Bevilacqua S; Glauber M; Biagini A; Tanganelli P
    J Am Coll Cardiol; 2004 May; 43(9):1670-6. PubMed ID: 15120829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.